SK286075B6 - Použitie bradykardických látok a voliteľne jednejďalšej zlúčeniny pôsobiacej na srdce - Google Patents

Použitie bradykardických látok a voliteľne jednejďalšej zlúčeniny pôsobiacej na srdce Download PDF

Info

Publication number
SK286075B6
SK286075B6 SK1458-2002A SK14582002A SK286075B6 SK 286075 B6 SK286075 B6 SK 286075B6 SK 14582002 A SK14582002 A SK 14582002A SK 286075 B6 SK286075 B6 SK 286075B6
Authority
SK
Slovakia
Prior art keywords
cilobradine
active compound
optionally another
treatment
another heart
Prior art date
Application number
SK1458-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK14582002A3 (sk
Inventor
J�Rgen D�Mmgen
Brian Guth
Randolph Seidler
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of SK14582002A3 publication Critical patent/SK14582002A3/sk
Publication of SK286075B6 publication Critical patent/SK286075B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1458-2002A 2000-04-13 2001-04-07 Použitie bradykardických látok a voliteľne jednejďalšej zlúčeniny pôsobiacej na srdce SK286075B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10018401A DE10018401A1 (de) 2000-04-13 2000-04-13 Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
PCT/EP2001/004034 WO2001078699A2 (de) 2000-04-13 2001-04-07 Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen

Publications (2)

Publication Number Publication Date
SK14582002A3 SK14582002A3 (sk) 2003-03-04
SK286075B6 true SK286075B6 (sk) 2008-03-05

Family

ID=7638652

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1458-2002A SK286075B6 (sk) 2000-04-13 2001-04-07 Použitie bradykardických látok a voliteľne jednejďalšej zlúčeniny pôsobiacej na srdce

Country Status (33)

Country Link
US (2) US7208508B2 (ru)
EP (2) EP1276476B1 (ru)
JP (1) JP3905386B2 (ru)
KR (1) KR20020089453A (ru)
CN (1) CN1245963C (ru)
AT (1) ATE330588T1 (ru)
AU (2) AU7048401A (ru)
BG (1) BG65816B1 (ru)
BR (1) BR0109996A (ru)
CA (2) CA2575059A1 (ru)
CY (1) CY1105081T1 (ru)
CZ (1) CZ300549B6 (ru)
DE (2) DE10018401A1 (ru)
DK (1) DK1276476T3 (ru)
EA (1) EA006977B1 (ru)
EE (1) EE05099B1 (ru)
ES (1) ES2266216T3 (ru)
HR (1) HRP20020815A2 (ru)
HU (1) HU228387B1 (ru)
IL (2) IL152103A0 (ru)
ME (1) MEP45908A (ru)
MX (1) MXPA02009935A (ru)
NO (1) NO330311B1 (ru)
NZ (1) NZ521934A (ru)
PL (1) PL215235B1 (ru)
PT (1) PT1276476E (ru)
RS (1) RS51478B (ru)
SI (1) SI1276476T1 (ru)
SK (1) SK286075B6 (ru)
TR (1) TR200202326T2 (ru)
UA (1) UA78679C2 (ru)
WO (1) WO2001078699A2 (ru)
ZA (1) ZA200208162B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
SI1362590T1 (en) * 2002-07-25 2004-04-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP3045174A1 (en) * 2003-01-31 2016-07-20 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
ES2404939T3 (es) * 2005-06-27 2013-05-29 Daiichi Sankyo Company, Limited Preparación farmacéutica que contiene un antagonista del receptor de la angiotensina II y un bloqueador de los canales de calcio
US20090247572A1 (en) * 2005-08-23 2009-10-01 Koichi Wada Agent for treating atrial fibrillation
EP1762179A1 (en) 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
EP1908469A1 (en) * 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
MX346039B (es) 2009-05-20 2017-03-03 Boehringer Ingelheim Vetmedica Gmbh Solucion farmaceutica bebible de telmisartan.
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
KR101296743B1 (ko) * 2011-02-17 2013-08-20 한국과학기술연구원 심근 비대증 진단용 바이오마커 및 이를 이용한 심근 비대증 진단 방법
BR112014003117A2 (pt) 2011-08-12 2017-06-13 Boehringer Ingelheim Vetmedica Gmbh inibidores da corrente funny (if) para uso em um método de tratamento e prevenção de insuficiência cardíaca em felino
EP2953612A1 (en) 2013-02-11 2015-12-16 Boehringer Ingelheim Vetmedica GmbH Kit-of-parts
CA3067918A1 (en) 2017-07-07 2019-01-10 Boehringer Ingelheim Vetmedica Gmbh Angiotensin ii receptor antagonish for the prevention or treatment of hypertension in cats
KR102398532B1 (ko) 2020-07-20 2022-05-13 한림대학교 산학협력단 중증 지주막하출혈 진단용 조성물
KR102331806B1 (ko) 2020-07-20 2021-12-01 한림대학교 산학협력단 중증 지주막하출혈 진단용 바이오 마커

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759125A (fr) 1969-11-19 1971-05-18 Boehringer Sohn Ingelheim Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
DE3119874A1 (de) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US5175157A (en) * 1985-11-27 1992-12-29 Boehringer Ingelheim Gmbh Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3541811A1 (de) * 1985-11-27 1987-06-04 Thomae Gmbh Dr K Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5308853A (en) * 1991-12-20 1994-05-03 Warner-Lambert Company Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
RU2078536C1 (ru) * 1993-09-02 1997-05-10 Украинский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско Способ определения клинической эффективности применения верапамила и дилтиазема у больных гипертрофической кардиомиопатией
PL313621A1 (en) * 1993-09-24 1996-07-08 Procter & Gamble Novel 14-aminosteroid compounds containing desoxy oxygen-substituted sugar
US5595987A (en) * 1994-07-22 1997-01-21 The Trustees Of Columbia University In The City Of New York Method of slowing ventricular arrhythmias using zatebradine
US6083991A (en) * 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment
DE19741635A1 (de) * 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
ID27664A (id) 1998-07-10 2001-04-19 Novartis Ag Kombinasi antihipersensitif dari valsartan dan penghalang saluran kalsium
DE10018401A1 (de) 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
CA2435526A1 (en) 2002-07-25 2004-01-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography

Also Published As

Publication number Publication date
EA200201053A1 (ru) 2003-02-27
EP1276476A2 (de) 2003-01-22
DE50110262D1 (de) 2006-08-03
EP1666042A2 (de) 2006-06-07
AU2001270484B2 (en) 2007-01-25
EP1276476B1 (de) 2006-06-21
CA2575059A1 (en) 2001-10-25
NZ521934A (en) 2007-05-31
MEP45908A (en) 2011-02-10
CN1245963C (zh) 2006-03-22
HUP0300917A2 (hu) 2003-08-28
EP1666042A3 (de) 2006-06-21
US20040014795A1 (en) 2004-01-22
US7208508B2 (en) 2007-04-24
EA006977B1 (ru) 2006-06-30
ES2266216T3 (es) 2007-03-01
CZ300549B6 (cs) 2009-06-10
BR0109996A (pt) 2003-05-27
PL215235B1 (pl) 2013-11-29
HU228387B1 (en) 2013-03-28
IL152103A0 (en) 2003-07-31
WO2001078699A3 (de) 2002-06-20
CZ20023752A3 (cs) 2003-03-12
NO330311B1 (no) 2011-03-28
PL357827A1 (en) 2004-07-26
HUP0300917A3 (en) 2009-04-28
CY1105081T1 (el) 2009-11-04
EE05099B1 (et) 2008-12-15
ATE330588T1 (de) 2006-07-15
DE10018401A1 (de) 2001-10-25
EE200200590A (et) 2004-04-15
WO2001078699A2 (de) 2001-10-25
HRP20020815A2 (en) 2004-12-31
BG65816B1 (bg) 2010-01-29
IL152103A (en) 2008-07-08
RS51478B (sr) 2011-04-30
ZA200208162B (en) 2003-10-17
NO20024924D0 (no) 2002-10-11
UA78679C2 (en) 2007-04-25
CA2404120C (en) 2008-01-22
PT1276476E (pt) 2006-09-29
TR200202326T2 (tr) 2003-03-21
JP3905386B2 (ja) 2007-04-18
KR20020089453A (ko) 2002-11-29
JP2003535050A (ja) 2003-11-25
CN1422153A (zh) 2003-06-04
US20070155679A1 (en) 2007-07-05
SK14582002A3 (sk) 2003-03-04
CA2404120A1 (en) 2001-10-25
AU7048401A (en) 2001-10-30
DK1276476T3 (da) 2006-08-14
NO20024924L (no) 2002-10-11
MXPA02009935A (es) 2003-02-12
BG107103A (bg) 2003-04-30
YU76902A (sh) 2006-05-25
SI1276476T1 (sl) 2006-10-31

Similar Documents

Publication Publication Date Title
US20070155679A1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
TWI389689B (zh) 氟利本西林（ｆｌｉｂａｎｓｅｒｉｎ）於治療停經前性慾疾病之用途
EA007274B1 (ru) Применение флибансерина для лечения половых расстройств
CA2642850A1 (en) Combination of alpha-2 receptor agonist (clonidine) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
CN101347427A (zh) 一种沙坦化合物或其可药用盐和钙通道阻断剂或可药用盐的复方
SK284937B6 (sk) Použitie prokineticky účinného antiemetika a tramadolu na výrobu liečiva na liečenie migrény
JP2002538102A (ja) 光学的に純粋なｒ（＋）オンダンセトロンを使用する無呼吸および無呼吸障害の治療方法
US20030171391A1 (en) Ambroxol for the treatment of chronic pain
US20150079183A1 (en) Lercanidipine Hydrochloride and Losartan Potassium Compound Preparation and Preparation Method Thereof
KR100325793B1 (ko) 불안신경증치료제
EP0471388B1 (de) Mittel zur Behandlung der Herzinsuffizienz
SK14552001A3 (sk) Použitie osanetantu na prípravu farmaceutických prostriedkov použiteľných na liečenie porúch nálady
KR20010021796A (ko) 선택성 세로토닌 재흡수 억제제 (ｓｓｒｉ)를 사용하는심장 질환의 치료 및 예방법
SK9772003A3 (sk) R- a S-enantiomér 2-amino-1-(4-hydroxy-3- metánsulfónamidofenyl)etanolu, farmaceutický prostriedok s ich obsahom a ich použitie
CN106668865A (zh) 用于治疗脑缺血的药物组合物、制剂及其应用
JP2001520194A (ja) うつ病治療のためのモキソニジンの使用
CN101361736A (zh) 一种沙坦化合物或其可药用盐和钙通道阻断剂或可药用盐的复方

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20160407